We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$12.7B
Cap. Flow %
-6.33%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,430
Increased
3,737
Reduced
3,810
Closed
1,252

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.53%
2 Financials 4.78%
3 Healthcare 3.89%
4 Industrials 3.6%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTAK icon
8676
Catheter Precision
VTAK
$919K
0
NYMX
8677
DELISTED
Nymox Pharmaceutical Corp
NYMX
$46K ﹤0.01%
23,544
+4,386
+23% +$9.3K
APTO
8678
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$46K ﹤0.01%
+51
New +$46.2K
DS
8679
PUT
DELISTED
Drive Shack Inc.
DS
$46K ﹤0.01%
10,300
-13,300
-56% -$60K
AXU
8680
CALL
DELISTED
Alexco Resource Corp
AXU
$46K ﹤0.01%
37,700
+21,400
+131% +$25.4K
HOS
8681
CALL
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$46K ﹤0.01%
37,000
+21,100
+133% +$32K
OTIV
8682
DELISTED
OTI On Track Innovations Ltd
OTIV
$46K ﹤0.01%
+73,727
New +$55K
BRS
8683
PUT
DELISTED
Bristow Group, Inc.
BRS
$46K ﹤0.01%
41,300
+26,500
+179% +$57.6K
OHAI
8684
DELISTED
OHA Investment Corporation
OHAI
$46K ﹤0.01%
38,615
+23,909
+163% +$28.6K
HPJ
8685
CALL
DELISTED
Highpower International Inc
HPJ
$46K ﹤0.01%
15,900
-15,200
-49% -$45.3K
QRHC icon
8686
Quest Resource Holding
QRHC
$28M
$45K ﹤0.01%
27,157
+13,161
+94% +$20.6K
ATYR
8687
aTyr Pharma
ATYR
$47.8M
$45K ﹤0.01%
5,782
+3,534
+157% +$25.2K
TA
8688
CALL
DELISTED
TravelCenters of America LLC
TA
$45K ﹤0.01%
+2,180
New +$49.6K
NBRV
8689
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$45K ﹤0.01%
73
+12
+20% +$6.54K
PER
8690
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$45K ﹤0.01%
19,160
-23,935
-56% -$54.6K
ALT icon
8691
PUT
Altimmune
ALT
$572M
$44K ﹤0.01%
+15,200
New +$45.3K
CAAS icon
8692
China Automotive Systems
CAAS
$133M
$44K ﹤0.01%
+13,730
New +$43.9K
EVC icon
8693
PUT
Entravision Communication
EVC
$1.03B
$44K ﹤0.01%
13,600
-2,100
-13% -$7.77K
LPCN icon
8694
CALL
Lipocine
LPCN
$16.9M
$44K ﹤0.01%
1,124
-158
-12% -$4.85K
PULM icon
8695
Pulmatrix
PULM
$6.39M
$44K ﹤0.01%
1,715
+1,387
+423% +$46.4K
SBET icon
8696
Sharplink Inc
SBET
$1.31B
$44K ﹤0.01%
100
+44
+79% +$19.8K
SMMT icon
8697
Summit Therapeutics
SMMT
$10.4B
$44K ﹤0.01%
23,783
+5,782
+32% +$9.48K
FGH
8698
DELISTED
FG Group Holdings Inc.
FGH
$44K ﹤0.01%
+25,123
New +$41.9K
CYRN
8699
DELISTED
CYREN Ltd.
CYRN
$44K ﹤0.01%
+1,016
New +$50.3K
ADMA icon
8700
CALL
ADMA Biologics
ADMA
$2B
$43K ﹤0.01%
+11,300
New +$39.9K

Similar funds

Citadel Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $12.7B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.

  • Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Citadel Advisors opened 1,430 new positions and closed 1,252 in Q1 2019.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.